Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Emicizumab in Patients With Acquired Hemophilia A: Multicenter, Single-arm, Open-label Clinical Trial

NCT05345197 is registered in ClinicalTrials.gov with University of Washington as lead sponsor.

NCT NCT05345197
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05345197 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Emicizumab in Patients With Acquired Hemophilia A: Multicenter, Single-arm, Open-label Clinical Trial
Lead sponsor
University of Washington
Phase
Phase 2
Overall status
Active, not recruiting
Start date
August 31, 2022
Completion date
December 31, 2026
Enrollment
51 (estimated)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

acquired hemophilia a